Samuel R. Little
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Samuel R. Little has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Steve C. C. Shih
Department of Electrical and Computer Engineering, Concordia University, Montreal, Quebec, Canada
3 shared publications - Angela B. V. Quach
Centre for Applied Synthetic Biology Concordia University Montréal Québec H3G 1M8 Canada
2 shared publications Fatemeh Gholizadeh
Department of Biology, Concordia University , Montreal, Quebec
2 shared publications- Peter J. Darlington
Department of Biology, School of Health, Concordia University , Montréal, Québec
2 shared publications Alison Hirukawa
DropGenie Boston MA 02111 USA
1 shared publicationEric Han
Department of Medicine, McGill University , Montreal, Quebec
1 shared publication
Latest Publications
- Open Access
- 22 May 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
Modulatory effects of M3 muscarinic acetylcholine receptor on inflammatory profiles of human memory T helper cells
Memory T helper (Th) cells, generated in response to immunogenic challenges, are crucial in orchestrating adaptive immune responses. Acetylcholine (ACh), a key neurotransmitter of the parasympathetic nervous system, modulates immune function via muscarinic ACh receptors (mAChRs). This study investigates the role of mAChRs, particularly the M3 muscarinic ACh receptor (M3R), in regulating the cytokine and chemokine profile and NF-κB p65 activity in primary human memory Th cells. Memory Th cells were isolated from healthy donors and stimulated with anti-CD3/CD28/CD2 in the presence of oxotremorine-M (M1R–M5R agonist), atropine (M1R–M5R antagonist), or J104129 (M3R-selective antagonist). CHRM1–CHRM5 expression was quantified using RT-qPCR. M3R and phosphorylated NF-κB p65 were analyzed by Western blot. IFN-γ, IL-17A, and IL-4 were assessed by ELISA, while intracellular cytokine and chemokine receptor expression were measured by flow cytometry. CHRM3 knockout was performed using CRISPR-Cas9. Memory Th cells expressed all 5 mAChR subtypes. Oxotremorine-M increased IFN-γ and IL-17A while reducing IL-4 in an atropine-sensitive manner. Blocking or knocking out M3R prevented oxotremorine-M–induced increases in IFN-γ and IL-17A, but the suppression of IL-4 remained unchanged. Stimulation of mAChRs, particularly M3R, enhanced NF-κB p65 activity but did not affect chemokine receptor expression, cell proliferation, viability, or M3R levels. These findings indicate that mAChRs, including M3R, drive a pro-inflammatory memory Th-cell response through NF-κB p65 activation, while IL-4 suppression occurs independently of M3R. Targeting M3R specifically may provide a strategy for modulating adaptive immunity and treating inflammatory diseases.
- 22 May 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
Open AccessModulatory effects of M3 muscarinic acetylcholine receptor on inflammatory profiles of human memory T helper cells
Memory T helper (Th) cells, generated in response to immunogenic challenges, are crucial in orchestrating adaptive immune responses. Acetylcholine (ACh), a key neurotransmitter of the parasympathetic nervous system, modulates immune function via muscarinic ACh receptors (mAChRs). This study investigates the role of mAChRs, particularly the M3 muscarinic ACh receptor (M3R), in regulating the cytokine and chemokine profile and NF-κB p65 activity in primary human memory Th cells. Memory Th cells were isolated from healthy donors and stimulated with anti-CD3/CD28/CD2 in the presence of oxotremorine-M (M1R–M5R agonist), atropine (M1R–M5R antagonist), or J104129 (M3R-selective antagonist). CHRM1–CHRM5 expression was quantified using RT-qPCR. M3R and phosphorylated NF-κB p65 were analyzed by Western blot. IFN-γ, IL-17A, and IL-4 were assessed by ELISA, while intracellular cytokine and chemokine receptor expression were measured by flow cytometry. CHRM3 knockout was performed using CRISPR-Cas9. Memory Th cells expressed all 5 mAChR subtypes. Oxotremorine-M increased IFN-γ and IL-17A while reducing IL-4 in an atropine-sensitive manner. Blocking or knocking out M3R prevented oxotremorine-M–induced increases in IFN-γ and IL-17A, but the suppression of IL-4 remained unchanged. Stimulation of mAChRs, particularly M3R, enhanced NF-κB p65 activity but did not affect chemokine receptor expression, cell proliferation, viability, or M3R levels. These findings indicate that mAChRs, including M3R, drive a pro-inflammatory memory Th-cell response through NF-κB p65 activation, while IL-4 suppression occurs independently of M3R. Targeting M3R specifically may provide a strategy for modulating adaptive immunity and treating inflammatory diseases.
- Open Access
- 26 August 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (21)
A Tri‐Droplet Liquid Structure for Highly Efficient Intracellular Delivery in Primary Mammalian Cells Using Digital Microfluidics
Automated techniques for mammalian cell engineering are needed to examine a wide range of unique genetic perturbations especially when working with precious patient samples. An automated and miniaturized technique making use of digital microfluidics to electroporate a minimal number of mammalian cells (≈40 000) at a time on a scalable platform is introduced. This system functions by merging three droplets into a continuous droplet chain, which is called a triDrop. In the triDrop configuration, the outer droplets are comprised of high‐conductive liquid while an inner or middle droplet comprising of low‐conductivity liquid that contains the cells and biological payloads. In this work, it is shown that applying a voltage to the outer droplets generates an effective electric field throughout the tri‐droplet structure allowing for insertion of the biological payload into the cells without sacrificing long‐term cell health. This technique is shown for a range of biological payloads including plasmids, mRNA, and fully formed proteins being inserted into adherent and suspension cells which include primary T‐cells. The unique features of flexibility and versatility of triDrop show that the platform can be used for the automation of multiplexed gene edits with the benefits of low reagent consumption and minimal cell numbers.
- 26 August 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (21)
Open AccessA Tri‐Droplet Liquid Structure for Highly Efficient Intracellular Delivery in Primary Mammalian Cells Using Digital Microfluidics
Automated techniques for mammalian cell engineering are needed to examine a wide range of unique genetic perturbations especially when working with precious patient samples. An automated and miniaturized technique making use of digital microfluidics to electroporate a minimal number of mammalian cells (≈40 000) at a time on a scalable platform is introduced. This system functions by merging three droplets into a continuous droplet chain, which is called a triDrop. In the triDrop configuration, the outer droplets are comprised of high‐conductive liquid while an inner or middle droplet comprising of low‐conductivity liquid that contains the cells and biological payloads. In this work, it is shown that applying a voltage to the outer droplets generates an effective electric field throughout the tri‐droplet structure allowing for insertion of the biological payload into the cells without sacrificing long‐term cell health. This technique is shown for a range of biological payloads including plasmids, mRNA, and fully formed proteins being inserted into adherent and suspension cells which include primary T‐cells. The unique features of flexibility and versatility of triDrop show that the platform can be used for the automation of multiplexed gene edits with the benefits of low reagent consumption and minimal cell numbers.
- 22 February 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (9) , 4039-4047
Viral Generation, Packaging, and Transduction on a Digital Microfluidic Platform
Viral-based systems are a popular delivery method for introducing exogenous genetic material into mammalian cells. Unfortunately, the preparation of lentiviruses containing the machinery to edit the cells is labor-intensive, with steps requiring optimization and sensitive handling. To mitigate these challenges, we introduce the first microfluidic method that integrates lentiviral generation, packaging, and transduction. The new method allows the production of viral titers between 106 and 107 (similar to macroscale production) and high transduction efficiency for hard-to-transfect cell lines. We extend the technique for gene editing applications and show how this technique can be used to knock out and knock down estrogen receptor gene─a gene prominently responsible for 70% of breast cancer cases. This new technique is automated with multiplexing capabilities, which have the potential to standardize the methods for viral-based genome engineering.
- 22 February 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (9) , 4039-4047
Viral Generation, Packaging, and Transduction on a Digital Microfluidic Platform
Viral-based systems are a popular delivery method for introducing exogenous genetic material into mammalian cells. Unfortunately, the preparation of lentiviruses containing the machinery to edit the cells is labor-intensive, with steps requiring optimization and sensitive handling. To mitigate these challenges, we introduce the first microfluidic method that integrates lentiviral generation, packaging, and transduction. The new method allows the production of viral titers between 106 and 107 (similar to macroscale production) and high transduction efficiency for hard-to-transfect cell lines. We extend the technique for gene editing applications and show how this technique can be used to knock out and knock down estrogen receptor gene─a gene prominently responsible for 70% of breast cancer cases. This new technique is automated with multiplexing capabilities, which have the potential to standardize the methods for viral-based genome engineering.